OPEN APP
Home >Companies >Natco Pharma net profit decline 9% in September quarter
Photo: Reuters
Photo: Reuters

Natco Pharma net profit decline 9% in September quarter

Sales of active pharmaceutical ingredients, the key raw materials that go into the manufacture of drugs, declined 30% to `52 crore

Hyderabad: Natco Pharma Ltd on Friday posted a 9% fall in net profit in the quarter ended 30 September due to declining sales of active pharmaceutical ingredients.

The company reported a net profit of 29.6 crore in the three months compared with 32.4 crore in the year-ago period. Sales rose 7.2% to 235 crore.

Sales of generic drugs, which contribute about three-fourths of sales, grew 34% to 159 crore from 119 crore in the year-ago period. Sales of active pharmaceutical ingredients, the key raw materials that go into the manufacture of drugs, declined 30% to 52 crore.

Its operating profit margin declined 252 basis points year-on-year to 24.9% against ICICIdirect estimate of 26%, mainly on account of an increase in employee expenses, ICICIdirect said.

One basis point is one-hundredth of a percentage point.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Close
×
Edit Profile
My ReadsRedeem a Gift CardLogout